132 related articles for article (PubMed ID: 12512936)
1. Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes.
Thomas MG; Santa Coloma TA; Correale J; Boccacci GL
Neurochem Res; 2002 Nov; 27(11):1305-12. PubMed ID: 12512936
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption.
Kuhlmann CR; Tamaki R; Gamerdinger M; Lessmann V; Behl C; Kempski OS; Luhmann HJ
J Neurochem; 2007 Jul; 102(2):501-7. PubMed ID: 17419808
[TBL] [Abstract][Full Text] [Related]
3. Regulation of renin secretion through reversible phosphorylation of myosin by myosin light chain kinase and protein phosphatase type 1.
Kim MH; Kim SH; Kim HS; Chang JW; Hong YS; Kim HW; Park CS
J Pharmacol Exp Ther; 1998 Jun; 285(3):968-74. PubMed ID: 9618396
[TBL] [Abstract][Full Text] [Related]
4. Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart.
Cadete VJ; Sawicka J; Bekar LK; Sawicki G
Br J Pharmacol; 2013 Sep; 170(2):380-90. PubMed ID: 23822644
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of myosin light chain kinase inhibition on contractility, force development and myosin light chain 20 phosphorylation of rat cervical and thoracic duct lymphatics.
Nepiyushchikh ZV; Chakraborty S; Wang W; Davis MJ; Zawieja DC; Muthuchamy M
J Physiol; 2011 Nov; 589(Pt 22):5415-29. PubMed ID: 21930597
[TBL] [Abstract][Full Text] [Related]
6. Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.
Grimm M; Haas P; Willipinski-Stapelfeldt B; Zimmermann WH; Rau T; Pantel K; Weyand M; Eschenhagen T
Cardiovasc Res; 2005 Jan; 65(1):211-20. PubMed ID: 15621049
[TBL] [Abstract][Full Text] [Related]
7. An essential role of myosin light-chain kinase in the regulation of agonist- and fluid flow-stimulated Ca2+ influx in endothelial cells.
Watanabe H; Takahashi R; Zhang XX; Goto Y; Hayashi H; Ando J; Isshiki M; Seto M; Hidaka H; Niki I; Ohno R
FASEB J; 1998 Mar; 12(3):341-8. PubMed ID: 9506478
[TBL] [Abstract][Full Text] [Related]
8. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage.
Yuan SY; Wu MH; Ustinova EE; Guo M; Tinsley JH; De Lanerolle P; Xu W
Circ Res; 2002 Jun; 90(11):1214-21. PubMed ID: 12065325
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of collagen-induced arachidonic acid liberation by 1-(5-iodonaphthalene-1-sulphonyl)-1H-hexahydro-1,4-diazepine hydrochloride (ML-7), a myosin light chain kinase inhibitor, in washed rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1997 Nov; 54(9):1019-26. PubMed ID: 9374423
[TBL] [Abstract][Full Text] [Related]
10. Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines.
Kaneko K; Satoh K; Masamune A; Satoh A; Shimosegawa T
Pancreas; 2002 Jan; 24(1):34-41. PubMed ID: 11741180
[TBL] [Abstract][Full Text] [Related]
11. Biphasic myosin II light chain activation during clot retraction.
Egot M; Kauskot A; Lasne D; Gaussem P; Bachelot-Loza C
Thromb Haemost; 2013 Dec; 110(6):1215-22. PubMed ID: 23965920
[TBL] [Abstract][Full Text] [Related]
12. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
Han YJ; Hu WY; Piano M; de Lanerolle P
Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
[TBL] [Abstract][Full Text] [Related]
13. Glioma migration can be blocked by nontoxic inhibitors of myosin II.
Gillespie GY; Soroceanu L; Manning TJ; Gladson CL; Rosenfeld SS
Cancer Res; 1999 May; 59(9):2076-82. PubMed ID: 10232591
[TBL] [Abstract][Full Text] [Related]
14. Myosin light chain kinase inhibitors ML-7 and ML-9 inhibit mouse lung carcinoma cell attachment to the fibronectin substratum.
Isemura M; Mita T; Satoh K; Narumi K; Motomiya M
Cell Biol Int Rep; 1991 Oct; 15(10):965-72. PubMed ID: 1773444
[TBL] [Abstract][Full Text] [Related]
15. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration.
Garcia JG; Verin AD; Herenyiova M; English D
J Appl Physiol (1985); 1998 May; 84(5):1817-21. PubMed ID: 9572834
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation.
Zhao Y; Rhoades RA; Packer CS
Am J Physiol; 1996 Nov; 271(5 Pt 1):L768-74. PubMed ID: 8944720
[TBL] [Abstract][Full Text] [Related]
17. Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability.
Yuan Y; Huang Q; Wu HM
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1437-43. PubMed ID: 9087622
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell substrate stiffness influences neutrophil transmigration via myosin light chain kinase-dependent cell contraction.
Stroka KM; Aranda-Espinoza H
Blood; 2011 Aug; 118(6):1632-40. PubMed ID: 21652678
[TBL] [Abstract][Full Text] [Related]
19. Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.
Tohtong R; Phattarasakul K; Jiraviriyakul A; Sutthiphongchai T
Prostate Cancer Prostatic Dis; 2003; 6(3):212-6. PubMed ID: 12970723
[TBL] [Abstract][Full Text] [Related]
20. Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork.
Rosenthal R; Choritz L; Schlott S; Bechrakis NE; Jaroszewski J; Wiederholt M; Thieme H
Exp Eye Res; 2005 Jun; 80(6):837-45. PubMed ID: 15939040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
